Antoine Francis: LIFE – The Only Metric
Antoine Francis, Founder of Global Plasma Supply LTD, shared an insightful post on LinkedIn:
”From everywhere and anywhere I operate in the plasma industry, the numbers are more than statistics—they’re lives.
Every day, I think about:
The child in sub-Saharan Africa with hemophilia who may never reach adulthood because factor VIII isn’t available.
The mother in South Asia who survives childbirth only to face preventable complications because albumin was out of stock.
The patient with primary immunodeficiency in Southeast Asia who has never even heard of IVIG, let alone received it.
The science is clear. The solutions exist. But access is still dictated by postcode and purchasing power. That is not acceptable.
Through Global Plasma Supply LTD, we are pushing forward with strategies that unite operational excellence, ethical procurement, and a belief that every patient matters equally.
This is my life’s work, and it’s personal.
We will not stop until access to plasma-derived medicines is no longer a privilege but a given.”
Read the full article by Antoine Francis here.
Stay informed on the emerging in Hematology with Hemostasis Today.
-
Aug 20, 2025, 15:36Antoine Francis: LIFE - The Only Metric
-
Aug 20, 2025, 15:09World Stroke Academy: Rodrigo Guerrero Torrealba on Acute Vestibular Syndrome and Stroke
-
Aug 19, 2025, 14:27Living With a Blood Clot? Join NBCA’s Free PEP Talk for Support
-
Aug 19, 2025, 14:23EHC 2025: Young Voices Shaping the Future of Bleeding Disorders
-
Aug 19, 2025, 14:20Prakash Upreti: ECMO in High-Risk Pulmonary Embolism
-
Aug 20, 2025, 14:25Mattia Galli: Sex-related Differences in Platelet Reactivity in Patients Both On and Off Antiplatelet Therapy
-
Aug 20, 2025, 12:55Commentary from Giuseppe Lippi and Colleagues on Light Exposure, Platelet Function and Thrombus Formation
-
Aug 20, 2025, 05:48James Harte on Asundexian and Milvexian's Strong, Dose-dependent Interferences in Coagulation Assays
-
Aug 19, 2025, 18:18Hélène Gleitz-Broeders: Targeting Stromal Crosstalk to Reverse Bone Marrow Fibrosis
-
Aug 19, 2025, 17:58David Tregouet on Molecular Determinants of Thrombosis Recurrence Risk Across VTE Subtypes
-
Aug 18, 2025, 23:56Dr. Arun V. J Invites You to His Lecture on ‘AI and Data Sciences in Transfusion Medicine’ at the AI in Healthcare Conclave. Register now!
-
Aug 18, 2025, 23:50Safe and Efficient Thrombectomy with Artix System: Clinical Insights from Neil Desai and Colleagues
-
Aug 16, 2025, 14:42Mark Crowther Honors Davide Matino for Leading Promising Hemophilia Trial at McMaster University
-
Aug 14, 2025, 10:28Impressive 95% Clot Removal in a VTE Case: Symphony16F and Symphony24F Catheters
-
Jul 28, 2025, 14:55HORIBA Decoding High Efficiency in Hematology Lab: Free Online Workshop
-
Aug 20, 2025, 13:33Askat's Life with Hemophilia A after Access to Prophylactic Treatment Through the WFH Humanitarian Aid Program
-
Aug 19, 2025, 17:22Louise Bannon Encourages You to Support World Thrombosis Day!
-
Aug 17, 2025, 07:31Melissa Korn's story: Recognizing Pulmonary Embolism Symptoms Can Save Lives, NBCA
-
Aug 16, 2025, 14:18Christelle Orlando Highlights Breakthroughs in Thrombophilia Testing and AT Assays at ISTH 2025
-
Aug 15, 2025, 23:33Kacper Odziomek Excels in 2 Pharmacology Courses from Harvard Medical School